| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥12.14B | ¥11.69B | +3.8% |
| Cost of Sales | ¥7.60B | ¥7.40B | +2.7% |
| Gross Profit | ¥4.53B | ¥4.29B | +5.8% |
| SG&A Expenses | ¥3.39B | ¥3.41B | -0.5% |
| Operating Income | ¥1.14B | ¥878M | +30.3% |
| Non-operating Income | ¥75M | ¥48M | +57.5% |
| Non-operating Expenses | ¥19M | ¥21M | -8.6% |
| Ordinary Income | ¥1.20B | ¥905M | +32.6% |
| Profit Before Tax | ¥1.29B | ¥906M | +42.3% |
| Income Tax Expense | ¥377M | ¥298M | +26.5% |
| Net Income | ¥912M | ¥608M | +50.0% |
| Net Income Attributable to Owners | ¥912M | ¥608M | +50.0% |
| Total Comprehensive Income | ¥1.14B | ¥588M | +94.6% |
| Interest Expense | ¥3M | ¥3M | -18.3% |
| Basic EPS | ¥154.31 | ¥103.03 | +49.8% |
| Dividend Per Share | ¥40.00 | ¥40.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥15.15B | ¥14.12B | +¥1.04B |
| Cash and Deposits | ¥7.27B | ¥6.84B | +¥425M |
| Accounts Receivable | ¥3.78B | ¥3.57B | +¥216M |
| Inventories | ¥1.11B | ¥996M | +¥118M |
| Non-current Assets | ¥8.67B | ¥8.47B | +¥197M |
| Item | Value |
|---|---|
| Net Profit Margin | 7.5% |
| Gross Profit Margin | 37.4% |
| Current Ratio | 272.9% |
| Quick Ratio | 252.8% |
| Debt-to-Equity Ratio | 0.52x |
| Interest Coverage Ratio | 400.42x |
| Effective Tax Rate | 29.2% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +3.8% |
| Operating Income YoY Change | +30.2% |
| Ordinary Income YoY Change | +32.5% |
| Net Income Attributable to Owners YoY Change | +50.0% |
| Total Comprehensive Income YoY Change | +94.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 5.94M shares |
| Treasury Stock | 14K shares |
| Average Shares Outstanding | 5.91M shares |
| Book Value Per Share | ¥2,639.26 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥40.00 |
| Year-End Dividend | ¥52.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Chemical | ¥11.47B | ¥996M |
| Healthcare | ¥673M | ¥148M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥24.85B |
| Operating Income Forecast | ¥2.00B |
| Ordinary Income Forecast | ¥2.08B |
| Net Income Attributable to Owners Forecast | ¥1.50B |
| Basic EPS Forecast | ¥253.36 |
| Dividend Per Share Forecast | ¥38.00 |
| Property, Plant & Equipment | ¥7.04B | ¥7.07B | ¥-34M |
| Intangible Assets | ¥313M | ¥327M | ¥-15M |
| Goodwill | ¥114M | ¥127M | ¥-13M |
| Total Assets | ¥23.82B | ¥22.58B | +¥1.24B |
| Current Liabilities | ¥5.55B | ¥4.94B | +¥609M |
| Accounts Payable | ¥1.32B | ¥1.14B | +¥181M |
| Non-current Liabilities | ¥2.62B | ¥2.88B | ¥-266M |
| Long-term Loans | ¥1.15B | ¥1.41B | ¥-261M |
| Total Liabilities | ¥8.17B | ¥7.83B | +¥343M |
| Total Equity | ¥15.65B | ¥14.76B | +¥892M |
| Capital Stock | ¥585M | ¥585M | ¥0 |
| Capital Surplus | ¥635M | ¥614M | +¥21M |
| Retained Earnings | ¥13.81B | ¥13.20B | +¥605M |
| Treasury Stock | ¥-18M | ¥-51M | +¥33M |
| Owners' Equity | ¥15.65B | ¥14.76B | +¥892M |
| Working Capital | ¥9.60B | - | - |